No abstract available.
Coronary Aneurysm* ; Mucocutaneous Lymph Node Syndrome*

No abstract available.
Blood Glucose* ; Calcium* ; Humans ; Hypocalcemia* ; Hypoglycemia* ; Incidence* ; Infant, Newborn*

A case of esophagopleural fistula after pleuropneumonectomy is reported. A 59 years old male underwent right pleuropneumonectomy due to tuberculous empyema. The postoperative small esophagopleural fistula was confirmed by esophagogram and was initially managed by a conservative treatment. There was a persistent fistula on follow up esophagogram, therefore we planned the next treatment modality for obstruction of the fistula. For poor general conditions and arrhythmia, an esophageal stent was applied as a non-surgical method. At first, a covered-form stent was inserted, but it migrated to the stomach after 3 months. By using an uncovered-form stent, a complete obstruction of the esophagopleural fistula was achieved.
Arrhythmias, Cardiac ; Empyema, Tuberculous ; Esophageal Fistula ; Fistula* ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pneumonectomy ; Stents* ; Stomach

Partial anomalous pulmonary venous connection is frequently found in any ASD(atrial septal defect) patients. These patients are usually symptomatic, therefore, easily diagnosed as just simple ASD. We experienced a case of a 37-year-old female patient with ASD in which the left upper pulmonary vein was connected to SVC by the left inominate vein. The patient was diagnosed as simple ASD previously. During cardiac catheterization, we found a meaningful oxygen saturation step up between the SVC and its upper portion. Angiogram confirmed PAPVC. The surgical correction of anastomosis of PAPVC with left atrial appendage and direct closure of ASD were done. The patient was discharged 15 days later.
Adult ; Atrial Appendage ; Cardiac Catheterization ; Cardiac Catheters ; Female ; Heart Septal Defects, Atrial* ; Humans ; Oxygen ; Pulmonary Veins ; Veins

No abstract available.

BACKGROUND: The aim of this study is to evaluate our clinical experience with the Carbomedics heart valve prosthesis. MATERIAL AND METHOD: Between Aug. 1988 and Dec. 1998, 294 Carbomidics valves were implanted in 235 patients(mitral; 143, mitral and aortic; 59, aortic; 33) The mean age at operation is 40.0+/-12.3 years(range 7 to 68 years); 63.8% (150patients) were woman. Follow up was 97.4% complete and mean follow up time was 5.7years with a total of 1209.2 patient-years. RESULT: The hospital mortality was 8.9%(mitral; was 95.2+/-1.6%(mitral ; 94.9+/-2.1%, mitral and aortic 95.0+/-3.7%, aortic 96.2+/-3.8%). Actual freedom rates from complications(linearized rates in parentheses) were fllowings; thromboembolism 96.2+/-1.5%(0.59%pt-yr), valve thrombosis 96.7+/-1.4%(0.5%/pt/yr), anticoagulant related hemorrhage 98.3+/-1.0%(0.25%/pt-yr), perivalvular leak 99.0+/-1.4%(0.5%/pt-yr), endocarditis 98.7+/-1.0%(0.25%/pt-yr), perivalvular leak 99.0+/-0.7%(0.17%pt-yr), endocarditis 98.7+/-1.0%(0.17%+/-pt-yr) and overall valve-related complications 88.9+/-2.5%(1.68%/pt-yr). CONCLUSION: The clinical performance of the Carbomedics valve was quite satisfactory with a low incidence of valve related mortality and morbidity.
Endocarditis ; Female ; Follow-Up Studies ; Freedom ; Heart Valve Prosthesis ; Hemorrhage ; Hospital Mortality ; Humans ; Incidence ; Mortality ; Thromboembolism ; Thrombosis

No abstract available.
Acinetobacter calcoaceticus* ; Acinetobacter* ; Pneumonia*

The incidence of Congenital diaphragmatic hernia is 1 in 2000-5000 live births and hiatal hernia is even rarer especially in neonates. We experienced a case of congenital hiatal hernia (mixed type) in a week old female. Upon confirmation of the diagnosis, the surgery was done. Through the right thoracotomy, Belsey-Mark IV fundoplication was performed after the reduction of herniated viscera. The patient was fed 3 days after operation. there has been no complaint for 6 months after discharge. Therefore, we present this case with overall review of the literature.
Diagnosis ; Female ; Fundoplication ; Hernia, Diaphragmatic ; Hernia, Hiatal* ; Humans ; Incidence ; Infant, Newborn* ; Live Birth ; Thoracotomy ; Viscera

Coronary artery bypass grafting on the beating heart is no longer new to any cardiac surgeon. What matters nowadays is stablizing the heart without impairing the hemodynamics. We describe a simple and safer technique to move the anterolateral coronary to a center in the operation field. The empty blood bag connected to 50 cc syringe is put underneath the left venricle. Simply inflating the air into the blood bag gradually displaces the heart and rotate the lateral wall of the ventricle to the midline position. Therefore, we suggest "Blood Bag" method as a different way of exposing heart.
Coronary Artery Bypass ; Heart ; Hemodynamics ; Surgical Procedures, Minimally Invasive ; Syringes

PURPOSE: The purpose of this study is to present our preliminary experience of the temporary endovascular bypass (TEB) technique using an Enterprise stent for recanalization of acute intracranial artery (IA) occlusion. MATERIALS AND METHODS: Patients treated by TEB were enrolled in this retrospective study from January 2009 to May 2010. All the procedures consist of temporary partial deployment and subsequent retrieval of Enterprise stent, supplemented by intra-arterial infusion of urokinase (UK) and/or tirofiban. According to the thrombolysis in cerebral infarction (TICI) classification, recanalization was evaluated with initial and postprocedural angiography. Safety was evaluated related to the procedure and clinical outcomes were assessed by National Institute of Health Stroke Scale (NIHSS) score at discharge and modified Rankin scale (mRS) score at 3 months. RESULTS: Eleven patients (median NIHSS 12.8, mean age 61.6 years, male: female = 8:3) with acute IA occlusion were treated with TEB. All the patients presented with TICI 0, and the occluded vessel was the middle cerebral artery (n=7), the basilar artery (n=1), and the distal ICA occlusion (n = 3). IV infusion of tissue plasminogen activator (tPA) was done in 4 patients and mechanical thrombolysis with intra-arterial UK was performed in 9. Recanalization was achieved in 73% (8 patients; TICI > or = 2). There were no procedure-related complications except for two asymptomatic intracranial hemorrhages. Improvement (> or = 4 points on the NIHSS) and good outcome (mRS < or =2) after 90 days was shown in six patients (55%). One patient died 6 days after procedure. CONCLUSION: TEB may be a valuable treatment option in acute thromboembolic IA occlusion without stent implantation.
Angiography ; Arteries ; Basilar Artery ; Cerebral Infarction ; Female ; Glycosaminoglycans ; Humans ; Infusions, Intra-Arterial ; Intracranial Hemorrhages ; Mechanical Thrombolysis ; Middle Cerebral Artery ; Retrospective Studies ; Stents ; Stroke ; Tissue Plasminogen Activator ; Tyrosine ; Urokinase-Type Plasminogen Activator